P. Lipponen
- Oncology top 1%
- Cancer-related Molecular Pathways 15
- Cancer Immunotherapy and Biomarkers 14
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 18
- Cancer, Lipids, and Metabolism 14
- Breast Cancer Treatment Studies 14
-
- Prostate Cancer Treatment and Research 21
- Surgery top 2%
- Bladder and Urothelial Cancer Treatments 52
- Urinary and Genital Oncology Studies 26
- Biotechnology top 2%
P. Lipponen
147 papers receiving 5.2k citations
Peers
Comparison fields: 5 of 120
- Oncology 2.5k
- Cancer Research 1.3k
- Pulmonary and Respiratory Medicine 1.2k
- Surgery 1.6k
- Biotechnology 287
Countries citing papers authored by P. Lipponen
This map shows the geographic impact of P. Lipponen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Lipponen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Lipponen more than expected).
Fields of papers citing papers by P. Lipponen
This network shows the impact of papers produced by P. Lipponen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Lipponen. The network helps show where P. Lipponen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P. Lipponen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 28 | |
| 2 | 1999 | 80 | |
| 3 | 1997 | 46 | |
| 4 | 1996 | 17 | |
| 5 | 1996 | 38 | |
| 6 | 1995 | 52 | |
| 7 | 1995 | 15 | |
| 8 | 1994 | 27 | |
| 9 | 1994 | 27 | |
| 10 | 1994 | 126 | |
| 11 | 1993 | 212 | |
| 12 | 1993 | 11 | |
| 13 | 1993 | 31 | |
| 14 | 1993 | 18 | |
| 15 | Simple quantitation of immunohistochemical staining positivity in microscopy for histopathology routine | 1992 | 14 |
| 16 | 1992 | 1 | |
| 17 | 1992 | 14 | |
| 18 | 1991 | 42 | |
| 19 | Nuclear morphometry in grading transitional cell bladder cancer compared with subjective histological grading. | 1990 | 10 |
| 20 | 1990 | 17 |
About P. Lipponen
P. Lipponen is a scholar working on Cancer Research, Oncology, Surgery, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 147 papers that have together received 5.4k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (52 papers), Urinary and Genital Oncology Studies (26 papers), Prostate Cancer Treatment and Research (21 papers), Cancer Genomics and Diagnostics (18 papers), Cancer-related Molecular Pathways (15 papers), Cancer, Lipids, and Metabolism (14 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Breast Cancer Treatment Studies (14 papers). The work is most often cited by research in Oncology (2.5k citations), Cancer Research (1.3k citations), Pulmonary and Respiratory Medicine (1.2k citations), Surgery (1.6k citations) and Biotechnology (287 citations). P. Lipponen has collaborated with scholars based in Finland, Italy and Slovenia. Frequent co-authors include Matti Eskelinen, S. Aaltomaa, Karí Syrjänen, Veli‐Matti Kosma, M Eskelinen, Veli‐Matti Kosma, S. Vesalainen, Martti Talja, Martti Ala‐Opas and E. Alhava. Their work appears in journals such as European Urology, The Journal of Pathology, European Journal of Cancer, Journal of Cancer Research and Clinical Oncology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.